A synthetic NOD2 agonist, muramyl dipeptide (MDP)-Lys (L18) and IFN-β synergistically induce dendritic cell maturation with augmented IL-12 production and suppress melanoma growth

• FUJIMURA Taku

  Department of Dermatology, Tohoku University Graduate School of Medicine

• YAMASAKI Kenshi

  Department of Dermatology, Tohoku University Graduate School of Medicine

• HIDAKA Takanori

  Department of Dermatology, Tohoku University Graduate School of Medicine

• ITO Yumiko

  Department of Dermatology, Tohoku University Graduate School of Medicine

• AIBA Setsuya

  Department of Dermatology, Tohoku University Graduate School of Medicine

収録刊行物

• Journal of dermatological science

  Journal of dermatological science 62 (2), 107-115, 2011-05-01

キーワード

• Melanoma
• Immunotherapy
• MDP-Lys (L18)
• IFN-β

詳細情報

• CRID: 1573950400530650112
• NII論文ID: 10030891164
• NII書誌ID: AA1075636X
• ISSN: 09231811
• Web Site: https://search.jamas.or.jp/link/ui/2012000689
• 本文言語コード: en
• データソース種別:
  • CiNii Articles